Squar Milner Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Squar Milner Financial Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,098	Closed	-$685K	–	153
2020 Q2	$685K	Buy	1,098 +246	+29%	+$140K	0.39%	67
2020 Q1	$416K	Buy	852 +230	+37%	+$94.9K	0.25%	85
2019 Q4	$233K	Sell	622 -519	-45%	-$175K	0.12%	177
2019 Q3	$639K	Buy	1,141 +994	+676%	+$294K	0.33%	82
2019 Q2	$46K	Buy	147 +30	+26%	+$9.99K	0.03%	362
2019 Q1	$48K	Buy	117 +17	+17%	+$7K	0.04%	323
2018 Q4	$37K	Hold	100	–	–	0.04%	325
2018 Q3	$40K	Sell	100 -167	-63%	-$63.6K	0.04%	328
2018 Q2	$92K	Buy	+267	New	+$83.5K	0.08%	260

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squar Milner Financial Services's REGN Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Regeneron Pharmaceuticals (REGN) in Q3 2020, closing a stake of 1,098 shares — an estimated $685K sold.

Squar Milner Financial Services first reported a position in REGN in Q2 2018 and held it in 9 quarters. The position peaked at $685K in Q2 2020. 908 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

Squar Milner Financial Services reported no remaining Regeneron Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Squar Milner Financial Services sold 1,098 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $685K.
Squar Milner Financial Services first reported a position in Regeneron Pharmaceuticals in Q2 2018 and held it in 9 quarters.
Squar Milner Financial Services's Regeneron Pharmaceuticals position peaked at $685K in Q2 2020.
908 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.